CTTN and prostate carcinoma: piR-19166, downregulated in prostate carcinoma cells, inhibited cell migration by up to 40% in vitro and reduced metastasis by 75% in a mouse model through suppression of CTTN mRNA, a key component of CTTN/MMPs signaling pathway responsible for metastasis [206].